FDA Import Refusal 1FX-6522135-0/10002/1 — COMERCIALIZADORA FARMACEUTICA DE
The FDA refused shipment 1FX-6522135-0/10002/1 from COMERCIALIZADORA FARMACEUTICA DE (Mexico) on Aug 23, 2026. The refused product falls under Drugs and Biologics — DAPAGLIFLOZIN (ANTI-DIABETIC). Cited charge: 75 This firm has 1 other import refusal on record.
Refusal Details
- Date
- Aug 23, 2026
- Country
- Mexico
- Product Category
- Drugs and Biologics
- Product Code
- 61PCA70 DAPAGLIFLOZIN (ANTI-DIABETIC)
- Charges
- 75